Health News

INSULIN Act introduced

The American Diabetes Association (ADA) has backed the introduction of the bipartisan Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act by Sens. Jeanne Shaheen (D-NH) and Susan Collins (R-ME) today. This act will help address the outrageous costs for insulin and help remove barriers to make it more accessible for Americans.  The ADA has been the leading advocate for limiting cost-sharing for insulin at both the state and federal levels and increasing access to affordable insulin for both insured and uninsured people with diabetes. One in four people who use insulin report rationing this lifesaving drug, and our first priority is reducing costs for patients. In addition to limiting cost-sharing for insulin to $35 per month for individuals with commercial insurance plans, the INSULIN Act makes sure rebates stop inflating the price of insulin, biosimilar insulins can come to market more quickly, and insurers make these more affordable options available to patients. Furthermore, the INSULIN Act would help address the root cause in the insulin market which directly contributes to high pricing for patients.

Click Here to read the full article

(800) 441-2728